tgen Archives

Meet the finalists for Healthcare Leadership Awards

Doctor, Vacancy

Each year, AZ Business magazine hosts the Healthcare Leadership Awards to honor the women, men and institutions that bring excellence and innovation to Arizona’s healthcare sector. Az Business is proud to announce the 2016 Healthcare Leadership Awards finalists, who were chosen by a panel of industry experts and will be recognized at the Healthcare Leadership… Read More →

TGen traces source of disease outbreak

Health Insurance

The Translational Genomics Research Institute (TGen), working with international investigators, discovered the source of a potential deadly blood infection in more than 50 South American cancer patients. Using advanced genomic sequencing, TGen was able to track a potentially deadly and therapy-resistant fungus, Sarocladium kiliense, to a tainted anti-nausea medication given to dozens of cancer patients in Chile… Read More →

Hypervirulent strep outbreak identified by TGen

Krauss Honored For Science

The Translational Genomics Research Institute (TGen) helped state, local and tribal health officials identify an outbreak of “hypervirulent” strep bacteria in the American Southwest.  Identified in Flagstaff, from January to July 2015, this outbreak of the emm59 clone of group A Streptococcus is directly related to cases identified recently in New Mexico. This strain type appears to have evolved from a nationwide… Read More →

Wendy’s cool deal boosts TGen cancer research

cancer

During the months of March through April, a Frosty treat will provide a cool benefit for cancer research at the Translational Genomics Research Institute (TGen). Wendy’s restaurants in Phoenix are selling five free Jr. Frosty coupons for a $1 donation, while supplies last. All of the proceeds benefit TGen and its efforts towards earlier diagnostics and smarter… Read More →

TGen doctor presents at myeloma conference

bioscience

Dr. Jonathan Keats of the Translational Genomics Research Institute (TGen) will present research findings to the Arizona Myeloma Network (AzMN) when it hosts its 10th annual Living with Myeloma Conference on March 18-19. On March 18, from noon to 5:30 p.m. the conference includes a scientific roundtable in the Ballroom of Chaparral Suites, 5001 N. Scottsdale Road.… Read More →

ASU students raise funds for TGen cancer research

Cancer research

Students at Arizona State University have raised nearly $5,000 for pancreatic cancer research at the Translational Genomics Research Institute (TGen). Led by Lambda Chi Alpha, eight Greek social groups at ASU bought t-shirts, held a dunk tank and decorated their Greek letters during “Hunt for a Cure” events in November, which is Pancreatic Cancer Awareness Month.… Read More →

TGen: Dogs help advance new cancer treatments

Cancer research

A Science Translational Medicine review suggests integrating dogs with naturally occurring cancers into studies of new drug therapeutics could result in better treatments for our four-legged friends while helping inform therapeutic development for human cancers. The review, conducted by the Institute of Medicine (IOM) of the National Academy of Science, including faculty at the Translational Genomics Research Institute… Read More →

TGen finds protein that fuels invasive brain tumors

brain cancer

The Translational Genomics Research Institute (TGen) identified a protein called SGEF that promotes the survival of glioblastoma tumor cells and helps the cancer invade brain tissue. TGen researchers identified SGEF as a target for new brain cancer therapies in a study published Wednesday by Molecular Cancer Research, an American Association for Cancer Research journal. Glioblastoma multiforme, or… Read More →

TGen reports $174 million economic impact on Arizona

bioscience

Translational Genomics Research Institute (TGen) annual economic impact on Arizona has risen eight-fold over 8 years, reaching a total of $174 million annually, according to an independent financial report released Wednesday. Independent auditing firm Tripp Umbach of Pittsburgh’s report shows that TGen is responsible for $8.7 million is annual tax revenues to the state’s general… Read More →

Regents award TGen for outstanding service

bioscience

The Arizona Board of Regents presented the Translational Genomics Research Institute (TGen) with its 2015 Regents’ Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University (NAU). The award was presented at a Board of Regents dinner Thursday at the University of Arizona. The award was established… Read More →

TGen finds drug that could help treat brain tumors

brain

In a significant breakthrough, the Translational Genomics Research Institute (TGen) has identified a drug, propentofylline or PPF, that could help treat patients with deadly brain cancer. In a study published today in the Journal of NeuroOncology, TGen researchers report that PPF works to limit the spread of glioblastoma multiforme, or GBM — the most common primary tumor of… Read More →

TGen leads Stand Up To Cancer Dream Team

123rf.com: Siarhei Lenets

The Phoenix-based Translational Genomics Research Institute (TGen) will lead an international Stand Up To Cancer (SU2C) Dream Team of top cancer researchers in a $12 million effort to double the survival of patients with pancreatic cancer, the fourth leading cause of cancer death in the U.S. Dr. Daniel D. Von Hoff — TGen Physician-in-Chief and… Read More →

TGen shows liquid biopsy improves cancer patient care

Strategic Economic Development Plan

A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient’s cancer evolves and responds to treatment. In a study published today in Nature Communications, Dr. Muhammed Murtaza of TGen and Mayo Clinic, and colleagues, describe an extensive comparison between biopsy results… Read More →

TGen, HonorHealth study new therapy for pancreatic cancer

VisionGate

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth Research Institute and the Translational Genomics Research Institute (TGen). “Results from our clinical trial research showed a patient survival rate of nearly… Read More →